Trial result ·
Smartphone-Based Real-Time Assessment of Daytime Insomnia Symptoms With Suvorexant: A Randomized Clinical Trial.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This study tested a sleep drug called suvorexant in people with long-term insomnia. It included 40 people aged 60 to 85 years. By chance, 20 took suvorexant and 20 took a dummy pill. Neither the people nor the staff knew who got which. The pills were taken each night for 16 days. People answered a phone survey on daytime insomnia symptoms 4 times a day. They also filled in usual forms before and after the pills.
What they found
No one left the study. People filled in almost all of the phone surveys. Suvorexant eased insomnia more than the dummy pill did. The usual forms showed no clear gap between groups in daytime symptoms. The phone surveys did show a gap in tiredness and in thinking. These showed up at 1 or more times of the day.
What it means for patients
The authors say the phone surveys picked up daytime effects of the drug. The usual forms missed these effects. They say this fills an important gap in what is known. In this trial, suvorexant also eased insomnia compared with a dummy pill.
Why it is not certain yet
Only 40 people took part. The pills were taken for just 16 days, so longer effects are not known. Of the 40 people, 36 were women. Only people aged 60 to 85 took part. The abstract does not give details on side effects.
The registered trial
The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.
Source
Smartphone-Based Real-Time Assessment of Daytime Insomnia Symptoms With Suvorexant: A Randomized Clinical Trial.
PubMed · PMID 41490112We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Insomnia publications